Zurueck zur Suche

Reporte zur Charge U022984

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

32Reporte angezeigt
0Todesfaelle
2Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
FL 4 NY 3 NJ 2 OH 2 NC 2 PA 2 IL 2 TX 1 WV 1 MN 1 GA 1 OR 1

VAERS 2311503

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u022984

schwer
Staat
NJ
Alter
66,0
Geschlecht
F
Eingang
07.06.2022
Impfdatum
03.06.2022
Beginn
03.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Back pain Blood test abnormal Dizziness Hypertension Nervousness Syncope

Symptomtext

, Additional Details: about 5-10mins after recieving the vaccine pt complained of back pain/dizzy,fainting. sat her down gave water. she was very nervous. no site/neck,shouolder pain but back pain of the same side. she called husband. after staying for 15 mins she felt better to leave but had gone to urgent care.called in pm to follow up around 7pm. she was better. they did blood work at uc. bp was high and blood work showed a MI from past few months. nothing new. she said she was okay now. no pain or dizzy

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2552851

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u022984

moderat
Staat
FL
Alter
67,0
Geschlecht
F
Eingang
06.01.2023
Impfdatum
04.01.2023
Beginn
04.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Mobility decreased Musculoskeletal pain

Symptomtext

The patient reports that about an hour after the shot administration there was severe musculoskeletal pain and she could not lift her arm. The patients pain has now resolved but there is still significant redness and it has traveled down the arm and stopped just before the elbow.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
N/A
Vorherige Impfungen
-

VAERS 2505836

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

moderat
Staat
MN
Alter
73,0
Geschlecht
M
Eingang
11.11.2022
Impfdatum
02.06.2022
Beginn
03.06.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Injected limb mobility decreased Injection site pain Muscular weakness Pain

Symptomtext

Since the vaccination the patient has experienced pain in his left shoulder and reduced mobility of his arm. The patient shared he has been suffering with pain in his upper left arm and reduced mobility since the vaccination. Describes soreness with movement of left arm towards his back and when he raises it overhead (most severe reaching back). He denies pain when raising straight forward or out to the side. He reports a mild weakness related to the soreness with movement. Patient has expressed desiring imaging (MIR of shoulder) to further evaluate and treat; however, patient has not completed any imaging at the time of the report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2480401

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

moderat
Staat
IL
Alter
66,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
12.10.2022
Beginn
13.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cellulitis Chills Injected limb mobility decreased Injection site erythema Pyrexia Vomiting

Symptomtext

Patient reported not being able to move her right arm starting overnight the night she received the vaccines. She also stated she was vomiting, had fever chills, redness at the injection site. She called an ambulance and went the emergency room where she states she was told she had cellulitis due to either the injection site being contaminated or contamination of the vaccine. She was treated with cephalexin.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Macrolides & Ketolides
Vorherige Impfungen
-

VAERS 2599630

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
NY
Alter
37,0
Geschlecht
F
Eingang
20.03.2023
Impfdatum
07.01.2023
Beginn
07.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site swelling Pain

Symptomtext

The entire upper left arm swelled up for several days and hurt a great deal. The swelling has since subsided, but I am unable to completely lift my arm above my head without some pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
Dr. prescribed an x-ray test.
Aktuelle Erkrankungen
none
Vorgeschichte
hypothyroidism
Andere Medikamente
levothyroxine, Wellbutrin, Mirena IUD
Allergien
cephalosporins
Vorherige Impfungen
-

VAERS 2475842

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
FL
Alter
27,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
09.10.2022
Beginn
10.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Pain in extremity

Symptomtext

Administered on right arm and almost 24 hours the patient developed a large red spot with pain on the inside part of the arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None known
Vorgeschichte
None known
Andere Medikamente
NSAID
Allergien
Benadryl
Vorherige Impfungen
-

VAERS 2472650

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
TX
Alter
74,0
Geschlecht
F
Eingang
08.10.2022
Impfdatum
03.10.2022
Beginn
03.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site warmth

Symptomtext

Patient stated they noticed a red and warm area below the injection site to inside of elbow. When they arrived at the pharmacy on 10/04/22, they said that morning it was warm to the touch but was no longer warm as the day went on. They did not report fever or any other systemic symptoms after receieving vaccine. Followed up with patient on 10/08/22 and they stated the reaction has cleared completely

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2417585

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
OH
Alter
16,0
Geschlecht
F
Eingang
22.08.2022
Impfdatum
18.08.2022
Beginn
19.08.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Bandaemia C-reactive protein increased Cellulitis Fatigue Headache Immunisation reaction Immunodeficiency Injection site erythema Injection site pain Injection site swelling Laboratory test Leukocytosis Malaise Pyrexia Shift to the left Ultrasound scan normal Vomiting

Symptomtext

Received vaccines on 8/18. Beginning on the evening of 08/18, the patient began to experience unexpectedly severe pain in her L deltoid with associated swelling and erythema. She began to feel fatigued with malaise and a headache shortly after despite taking Tylenol Q6H for her symptoms. This continued until 08/19 when she became febrile to 101 F and experienced one episode of NBNB emesis follow dinner. The patient fevered again to 102 F on the day of admission which prompted her mother to seek care at a health care facility. She was started on IV clinda with rapid improvement within 24 hours. Difficult to say for certain if this was cellulitis vs vaccine reaction. Given her immunocompromised status we decided to be more cautious and treat as a true cellulitis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
2,0
Labordaten
Leukocytosis with left shift and bandemia, fever, elevated CRP and PCT. US showed no fluid collection.
Aktuelle Erkrankungen
-
Vorgeschichte
Evans syndrome ( ITP and hemolytic anemia d/t warm antibodies)
Andere Medikamente
Sirolimus, erythromycin, Nexplanon, desonide ointment for lips
Allergien
Amoxicillin/penicillin
Vorherige Impfungen
-

VAERS 2401333

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
WV
Alter
83,0
Geschlecht
F
Eingang
04.08.2022
Impfdatum
01.08.2022
Beginn
02.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pain Injection site swelling Monoplegia

Symptomtext

PATIENT REPORTED A SWOLLEN ARM AND INJECTION SITE. PATIENT STATED THE ARM WAS PARALYZED AND PAINFUL FOR A SHORT TIME

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2372151

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u022984

mild
Staat
NC
Alter
39,0
Geschlecht
F
Eingang
18.07.2022
Impfdatum
05.07.2022
Beginn
06.07.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling

Symptomtext

Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2310325

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
PA
Alter
66,0
Geschlecht
F
Eingang
06.06.2022
Impfdatum
03.06.2022
Beginn
03.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Chills Fibrin D dimer increased Headache Pain in extremity Peripheral swelling Ultrasound Doppler normal

Symptomtext

Headaches, chills, left arm pain and swelling

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Positive D-dimer on 6/05/22 Ultrasound of left upper extremity was negative for DVT on 6/05/22
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, hyperlipidemia, hypothyroidism, prediabetes, asthma, GERD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2298555

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
GA
Alter
54,0
Geschlecht
M
Eingang
21.05.2022
Impfdatum
18.05.2022
Beginn
20.05.2022
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site warmth

Symptomtext

Patient stated that the site of his pneumovax shot is red and warm. Started a couple of days after shot He stated he is sensitive to shots. Will keep an eye on it and use a cold pak.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2285420

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
OR
Alter
78,0
Geschlecht
F
Eingang
19.05.2022
Impfdatum
19.05.2022
Beginn
19.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Back pain Dysstasia Gait disturbance

Symptomtext

ACUTE STABBING LOWER BACK PAIN NEAR WASTE. PATIENT ATTEMPTED TO WALK OUT OF LOBBY SEVERAL MINUTES AFTER RECEIVING VACCINE, CALLED FOR HELP AND COULDN'T STAND. SHE SAT DOWN IN A CHAIR AND ASKED ME TO CALL EMERGENCY SERVICES, WHICH I DID. AFTER PARAMEDICS CHECKED HER OUT, SHE DECLINED TRANSPORT TO ED AND WALKED OUT OF STORE ON HER OWN POWER. SHE SAID THE PAIN WAS NO LONGER THERE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
PATIENT REPORTED HISTORY OR SCIATICA AND FALL ONE MONTH EARLIER
Andere Medikamente
FLUOXETINE 10 MG TWICE DAILY LEVOTHYROXINE 100 MCG ONCE DAILY ALENDRONATE 70 MG ONCE WEEKLY CARVEDILOL 6.25 MG ONCE DAILY IN THE MORNING AND TWO TABLETS AT NIGHT
Allergien
PENICILLIN
Vorherige Impfungen
-

VAERS 2277752

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u022984

mild
Staat
-
Alter
68,0
Geschlecht
M
Eingang
14.05.2022
Impfdatum
09.05.2022
Beginn
10.05.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Pain Swelling Tenderness

Symptomtext

Tenderness in the arm, swollen and pain. patient went to emergency room.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2273550

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
PA
Alter
34,0
Geschlecht
F
Eingang
12.05.2022
Impfdatum
08.05.2022
Beginn
08.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling

Symptomtext

Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: gave pt zyrtec 10mg to take at home, and advised trial of ibuprofen. pt will try and if no relief, will report to her dr

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2238108

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u022984

mild
Staat
FL
Alter
76,0
Geschlecht
F
Eingang
16.04.2022
Impfdatum
07.04.2022
Beginn
08.04.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site pain Vaccination site rash Vaccination site swelling

Symptomtext

Patient said suffered soreness, rash and swelling at the vaccination site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site pain
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
Famotadine 20mg; meclizine 25mg
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2234196

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
NJ
Alter
59,0
Geschlecht
M
Eingang
14.04.2022
Impfdatum
12.04.2022
Beginn
13.04.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Injection site swelling

Symptomtext

Patient developed pain,swelling over injection site that progressed to involving the upper arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Asthma,Allergic Rhinitis
Andere Medikamente
Singulair 10mg daily,Zyrtec 10mg daily,Albuterol HFA 2 puffs 4 times daily as needed.
Allergien
Seafood,Penicillin
Vorherige Impfungen
-

VAERS 2213366

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
FL
Alter
83,0
Geschlecht
F
Eingang
03.04.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Pain in extremity Peripheral swelling

Symptomtext

Patient's arm really swollen and red plus pain. Her doctor gave her a prednisone 5mg 6 days pack to help with the reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
High blood Pressure
Andere Medikamente
amlodipine, lisinopril, hydrochlorothiazide, atorvastatin
Allergien
PCN
Vorherige Impfungen
-

VAERS 2165603

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
HI
Alter
68,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
01.03.2022
Beginn
08.03.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pain Injection site pruritus

Symptomtext

Patient's Arm beneath the injection site was red, sore, tender to touch, painful but could still be moved. Pain and redness lasted for 3-4 days post vaccination. Pain started the same day, several hours post vaccination. Pictures were documented and sent to MD office. Treated pain with celecoxib x 2. Patient reported a little itchy on day 6 and still a little red.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
No medical test or laboratory test were done for this adverse event. HOWEVER, pharmacist wanted to submit this ALONG WITH COVID VACCINATION INFORMATION because this adverse event has occurred to this patient and anecdotally reported to me by 2 other patients who have received PPSV23 post COVID vaccinations, more so now post COVID vaccinations then ever before. This particular patient received Pfizer COVID vaccines on 2/17/21, 03/10/2021, and 12/19/2021. The other 2 patients were not my patients but they told me their story. Should we doing a little more patient warning to patients who have been receiving the PPSV23 post COVID ?
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
nka
Vorherige Impfungen
-

VAERS 2104920

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
SC
Alter
65,0
Geschlecht
F
Eingang
11.02.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Erythema Pain in extremity Peripheral swelling Skin warm

Symptomtext

Extreme swelling and pain first evening in upper arm progressing into bicep overnight. Second day becoming hot and red. Second night into morning, swelling and redness into elbow area. Had pre-scheduled appointment with oncologist on morning of 2/11/22. Diagnosed as cellulitis and prescribed Cephalexin 500 mg capsule 1-4x a day. Went to pick up prescription at same pharmacy where vaccine was administered and was told to report on CDC website.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
CLL
Vorgeschichte
-
Andere Medikamente
diltiazem, finasteride, hydroxycholorquine, aspirin, multi vitamin, fish oil
Allergien
None
Vorherige Impfungen
-

VAERS 2074905

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

mild
Staat
NC
Alter
29,0
Geschlecht
F
Eingang
30.01.2022
Impfdatum
28.01.2022
Beginn
29.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Decreased appetite Headache Lymphadenopathy Malaise Pain Peripheral swelling Pyrexia

Symptomtext

Approximately 16 hours after vaccine administration developed 101 degree fever, severe body aches, chills, severe headache, swelling in right arm and in right auxiliary lymph notes, mailaise, loss of appetite

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Covid 19 positive on 06 Jan 2022
Vorgeschichte
N/A
Andere Medikamente
Brevicon
Allergien
Clindamycin, ceclor, sulfa drugs, azithromycin
Vorherige Impfungen
Moderna COVID-19 vaccine second and third booster in Feb 2021 and Nov 2021, developed headache, fever, malaise, chills, body ach

VAERS 2706977

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
31.10.2023
Impfdatum
25.10.2023
Beginn
25.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE/PQC.; HCP calling to report AE for expired dose of PNEUMOVAX 23 PFS that was administered to a patient on 25OCT2023. Product expired 29JAN2023. Product did not have any previous temperature excursions. No side effects were reported. No other medical inform; This spontaneous report as received from a physician refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 25-OCT-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # U022984, expiration date 29-JAN-2023 (dose, route of administration and anatomical location were not reported) for prophylaxis (Expired product administered). The suspect vaccine did not undergo temperature excursion. No side effects were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2660144

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
AZ
Alter
-
Geschlecht
U
Eingang
25.07.2023
Impfdatum
22.06.2023
Beginn
22.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patients involved have not experienced any symptoms related to this adverse event at this time / No additional AE; Pharmacist calling to report adverse event regarding expired doses of PNEUMOVAX 23 that were inadvertently administered on 6/22/2023; This spontaneous report was received from a pharmacist, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported. On 22-JUN-2023, the patient was inadvertently vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 ml, once (lot number U022984 was verified to be valid, expiration date reported and confirmed as 29-JAN-2023) (route of administration and anatomical location were not provided) (Expired product administered). The patient did not experienced any symptoms related to this adverse event at this time. This is one of two reports received from the same reporter. ; Sender's Comments: US-009507513-2307USA011007:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2637501

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
26.05.2023
Impfdatum
24.05.2023
Beginn
24.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Pharmacist reported that an expired PNEUMOVAX 23 was administered to a patient. No additional AEs were reported. No further information provided. No PQC.; This spontaneous report has been received form a pharmacist, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 24-MAY-2023, the patient was vaccinated with an expired Pneumococcal Vaccine, Polyvalent (23-valent) (PENUMOVAX23) injection, as prophylaxis (lot number: U022984, which was determined to be valid as syringe, with an expiration date on 29-JAN-2023) (strength, dose, scheme, route and anatomical location of administration were not reported). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2602716

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
24.03.2023
Impfdatum
26.02.2023
Beginn
26.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; expired PNEUMOVAX 23 that was administered yesterday 2/26/2023.; This spontaneous report was received from a pharmacist and referred to a patient of unspecified age or gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reaction/allergies were not reported. On 26-FEB-2023, the patient was vaccinated with expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 milliliter, lot #U022984, expiration date: 29-JAN-2023, administered for prophylaxis (strength and route of administration were not provided) (Expired product administered). No additional adverse event details available.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2593425

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
NY
Alter
-
Geschlecht
M
Eingang
08.03.2023
Impfdatum
03.03.2023
Beginn
03.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; expired lot of PNEUMOVAX 23 was administered to 69 year old patient; This spontaneous report was received from a pharmacist and refers to a 69-year-old male patient. No information regarding patient's medical history, drug reactions or allergies and concomitant therapies was provided. On 03-MAR-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # U022984, expiration date: 29-JAN-2023, 0.5 milliliter once (route of administration and anatomical location were not reported) for prophylaxis (expired vaccine used). No further information and no additional adverse event were provided (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2591036

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
OH
Alter
67,0
Geschlecht
F
Eingang
03.03.2023
Impfdatum
03.03.2023
Beginn
03.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

I GAVE AN EXPIRED DOSE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
ALSO REC'D SHINGRIX #1 AND BOOSTRIX AT THE SAME TIME
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NA
Vorherige Impfungen
-

VAERS 2589057

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
CT
Alter
-
Geschlecht
U
Eingang
01.03.2023
Impfdatum
31.01.2023
Beginn
31.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; expired PNEUMOVAX 23; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug reaction/allergies were not reported. On 31-JAN-2023, the patient started therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #U022984, expiration date: 29-JAN-2023 (strength, dose, anatomical site of administration and route of administration were not provided) administered for prophylaxis (expired product administered). No additional adverse event (AE) reported (no adverse event). No temperature excursion reported for affected pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) prior to or at current call time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2584187

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
MA
Alter
-
Geschlecht
U
Eingang
20.02.2023
Impfdatum
15.02.2023
Beginn
15.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patient was administered and expired PNEUMOVAX 23.; This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On 15-FEB-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot number U022984 with expiration date 29-JAN-2023, administered for prophylaxis (strength, specific dosage, vaccination scheme, route of administration and anatomical site of application were not provided) (expired product administered) No other issues or concerns noted. No product quality complaint or temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2372109

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
18.07.2022
Impfdatum
30.12.2021
Beginn
30.06.2022
Tage bis Beginn
182,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

no adverse reaction or symptoms; a dose of PNEUMOVAX 23 was ordered to be given in December 2022. However, the dose was given today, 06/30/2022; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 30-DEC-2021, the patient was vaccinated with pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) (strength, dose, route of administration, anatomical location, indication, lot# and expiration date were not reported). On 30-JUN-2022, the patient was vaccinated with an early dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U022984, expiration date was not reported, but upon internal validation established as 29-JAN-2023; strength, dose, route of administration and anatomical location were not reported) for prophylaxis, which was ordered to be given in December 2022 (inappropriate schedule of product administration). The patient had no adverse reaction or symptoms from receiving either vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2215878

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
-
Alter
37,0
Geschlecht
M
Eingang
05.04.2022
Impfdatum
18.02.2022
Beginn
20.03.2022
Tage bis Beginn
30,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Duodenal ulcer Gastrooesophageal reflux disease Iron deficiency anaemia Oesophagogastroduodenoscopy abnormal Vascular cauterisation

Symptomtext

Iron deficiency anemia due to chronic blood loss - He was given 80 mg IV protonix, Zofran, 2 g IV magnesium in ED. On admission, GI was consulted. Underwent EGD on 3/21 which showed reflux esophagitis, and a deeply cratered non-bleeding duodenal ulcer with visible vessel. Vessel treated with bipolar cautery. Discharged home. ED visit to hospital admission within 6 weeks of receiving hte COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Duodenal ulcer
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2037798

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U022984

gering
Staat
AR
Alter
71,0
Geschlecht
F
Eingang
15.01.2022
Impfdatum
12.01.2022
Beginn
13.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lymphadenopathy Peripheral swelling

Symptomtext

ABNORMAL SWELLING OF THE UPPER ARM AND LYMPH NODES

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymphadenopathy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-